脏器官在ACE2-依赖的SARS-CoV-2感染期间显示病毒进入途径的冗余性

Jessica M Vanslambrouck1,2, Jessica A Neil3, Rajeev Rudraraju3

  • 1The Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Murdoch Children's Research Institute, Melbourne, Australia.

Journal of virology
|February 9, 2024
PubMed
概括

这项研究表明,SARS-CoV-2主要通过ACE2通过双重处理途径感染脏近道管细胞. 像利西诺普利尔这样的常见血压药物不会增加细胞对COVID-19感染的易感性.